Frontiers | Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Neurofilament als Serummarker für MS-Aktivität | SpringerLink
Neurofilament-Wert zeigt MS-Risiko an
Serum Neurofilament Light Polypeptide is a Biomarker for Inflammation in Cerebrospinal Fluid Caused by Fine Particulate Matter - Aerosol and Air Quality Research
Der Verlaufsmarkers NfL (Neurofilament light chain) in der ALS-App
Blood-based biomarker can detect, predict severity of traumatic brain injury | National Institutes of Health (NIH)
Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson's disease - ScienceDirect
Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19 | Science Translational Medicine
Cancers | Free Full-Text | Neurofilament Light Chain as A Biomarker for Brain Metastases
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study - The Lancet Neurology
a Boxplots of serum neurofilament light chain (NfL) levels in healthy... | Download Scientific Diagram
Einsatz von neurofilament light chain bei der Diagnose von Multipler Sklerose - Labor Berlin
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS | Neurology Neuroimmunology & Neuroinflammation